CD4+CD25+ regulatory T cells (TREG) in Systemic Lupus Erythematosus (SLE) patients: The possible influence of treatment with corticosteroids
- 1 May 2008
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 127 (2) , 151-157
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Enrichment of CD4+ CD25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoidsAnnals of the Rheumatic Diseases, 2006
- Targeting activated T cells: successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosisAnnals of the Rheumatic Diseases, 2006
- T cell tolerance and autoimmunityAutoimmunity Reviews, 2004
- Regulatory/suppressor T cells in health and diseaseArthritis & Rheumatism, 2004
- Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver diseaseJournal of Hepatology, 2004
- Human CD25+ regulatory T cells: two subsets defined by the integrins α4β7 or α4β1 confer distinct suppressive properties upon CD4+ T helper cellsEuropean Journal of Immunology, 2004
- Differential response of murine CD4+CD25+ and CD4+CD25– T cells to dexamethasone‐induced cell deathEuropean Journal of Immunology, 2004
- Mechanism of Transforming Growth Factor β–induced Inhibition of T Helper Type 1 DifferentiationJournal of Experimental Medicine, 2002
- Regulatory T Cell Clones Induced by Oral Tolerance: Suppression of Autoimmune EncephalomyelitisScience, 1994
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992